Skudexa 75 mg/25 mg film-coated tablets
- Name:
Skudexa 75 mg/25 mg film-coated tablets
- Company:
A. Menarini Pharmaceuticals Ireland Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/12/20

Click on this link to Download PDF directly
A. Menarini Pharmaceuticals Ireland Ltd

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 10 December 2020 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 6.1 - List of excipients
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Changes to side effect reporting details for the HPRA
Changes to "what Skudexa contains" (Opadry II white 85F1842 composed byOpadry II white 85F1842)
Updated on 10 December 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Changes to side effect reporting details for the HPRA
Changes to "what Skudexa contains" (Opadry II white 85F1842 composed byOpadry II white 85F1842)
Changes to member states
Updated on 14 January 2020 SPC
Reasons for updating
- Change to section 5.3 - Preclinical safety data
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update to section 5.3 with the results of Environmental Risk Assessment (ERA) studies for dexketoprofen.
Updated on 20 March 2019 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 25 October 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 25 October 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New product